News
The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...
Law Offices of Howard G. Smith reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Hims & Hers Health, Inc ...
4hon MSN
Find insight on Innovent Biologics, Fisher & Paykel Healthcare and more in the latest Market Talks covering Health Care.
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
The weight loss and diabetes drug Wegovy (also known as Ozempic) which is only available on prescription, should be on pharmacy shelves as of 1 July, drug maker Novo Nordisk confirmed. It ends a years ...
5h
Investor's Business Daily on MSNCan Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...
These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...
Gyre Therapeutics has a unique business model for evaluating and commercializing drugs in China. Find out why GYRE stock is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results